Azithromycin/chloroquine-diphosphateDrug ineffectiveness following off-label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1966卷 / 1期

关键词：

D O I：

10.1007/s40278-023-43540-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：87 / 87

相关论文

共 50 条

[41] TemozolomideThrombocytopenia following off-label use: case report
Reactions Weekly, 2025, 2040 (1) : 934 - 934
[42] NivolumabPsoriasis following an off-label use: case report
Reactions Weekly, 2018, 1717 (1) : 214 - 214
[43] DaratumumabHypogammaglobulinemia following off-label use: case report
Reactions Weekly, 2019, 1744 (1) : 111 - 111
[44] SunitinibCardiomyopathy following off-label use: case report
Reactions Weekly, 2023, 1971 (1) : 240 - 240
[45] PrednisoloneInefficacy following off-label use: case report
Reactions Weekly, 2022, 1910 (1) : 405 - 405
[46] TocilizumabNeutropenia following off-label use: case report
Reactions Weekly, 2021, 1853 (1) : 446 - 446
[47] GlibenclamideHypoglycaemia following off-label use: case report
Reactions Weekly, 2021, 1857 (1) : 162 - 162
[48] CatequentinibPneumothorax following off-label use: case report
Reactions Weekly, 2022, 1925 (1) : 158 - 158
[49] TolvaptanHypernatraemia following off-label use: case report
Reactions Weekly, 2019, 1753 (1) : 326 - 326
[50] ClonazepamMisidentification following off-label use: case report
Reactions Weekly, 2022, 1926 (1) : 171 - 171

← 1 2 3 4 5 →